Samuel Whiting - 02 Jul 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Issuer symbol
TPST
Transactions as of
02 Jul 2024
Net transactions value
+$9,951
Form type
4
Filing time
03 Jul 2024, 19:35:42 UTC
Previous filing
05 Jan 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPST Common Stock Purchase $9,951 +4,672 +95% $2.13 9,573 02 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,000 shares acquired under the Issuer's stock purchase plan.